Related Experiment Video
Updated: Jul 15, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Vaporization as a smokeless cannabis delivery system: a pilot study
D I Abrams1, H P Vizoso, S B Shade
1Community Consortium, Positive Health Program, San Francisco General Hospital, San Francisco, California, USA. dabrams@php.ucsf.edu
Abstract:
Although cannabis may have potential therapeutic value, inhalation of a combustion product is an undesirable delivery system. The aim of the study was to investigate vaporization using the Volcano((R)) device as an alternative means of delivery of inhaled Cannabis sativa. Eighteen healthy inpatient subjects enrolled to compare the delivery of cannabinoids by vaporization to marijuana smoked in a standard cigarette. One strength (1.7, 3.4, or 6.8% tetrahydrocannabinol (THC)) and delivery system was randomly assigned for each of the 6 study days. Plasma concentrations of Delta-9-THC, expired carbon monoxide (CO), physiologic and neuropsychologic effects were the main outcome measures. Peak plasma concentrations and 6-h area under the plasma concentration-time curve of THC were similar. CO levels were reduced with vaporization. No adverse events occurred. Vaporization of cannabis is a safe and effective mode of delivery of THC. Further trials of clinical effectiveness of cannabis could utilize vaporization as a smokeless delivery system.
More Related Videos
Related Concept Videos
Vaporization
Vapor Pressure Lowering
Oral Drug Delivery Systems: Introduction
Vapor Pressure
Atomic Absorption Spectroscopy: Atomization Methods
Transdermal Drug Delivery Systems

